Avrupa'daki Çalışmaları

Avrupa'daki Çalışmaları: EBMT (European Group For Blood and Marrow Transplantation) STWP (Solid Tumors Working Party) bünyesinde yürütülen Başkanı ve Koordinatörü olduğu çok merkezli Prospektif uluslararası çalışmalar:


  • A randomised study IT94 in relapsing germ cell tumours including patients in incomplete remission.
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: JL Pico, Bone Marrow Transplantation Unit,Hematology Division, Institut Gustave Roussy, Rue Camille Desmoulins, 94805 Villejuif Cedex, FRANCE
  • Randomised study (Random-ICE) EBMT phase-III randomized trial for small cell lung cancer (started June 1997, Completed in 2004)
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: Serge Leyvraz, Centre Pluridisciplinaire d'Oncologie, Rue de Bugnon 26 CHUV-10, 1011 Lausanne, SWITZERLAND.
  • A phase III randomised study on advanced ovarian carcinoma started in April 1998 (OVCAT Study) and completed in 2004.
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: J Ledermann, Department of Oncology, University College London Medical School, 91 Riding House Street, London W1P 8BT, UNITED KINGDOM.
  • PEGASE 03 High-dose cyclosphosphamide and Thiotepa after FEC for metastatic disease versus FEC alone
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: P Biron, Centre Leon Berard,Rue Laennec 28 ,69373 Lyon Cedex 08, FRANCE
  • PEGASE 05 A new phase 2 study on non metastatic inflammatory breast cancer
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: P Viens, Institute Paoli l. Calmettes, 232 Boulevard de Ste. Marguerite, 13273 Marseille Cedex 9, FRANCE.
  • Phase I study on the role of allografting in solid tumours
    Chairman: Taner Demirer (Ankara-Turkey), Principal İnvestigator: D Niederwieser, Klinik für Innere Medizin, Abt. Hematologie/Onkologie, Universitat Leipzig, Johannisallee 32, D-7010 Leipzig, Germany.
  • A randomised phase 3 study on relapsed platinum sensitive epithelial ovarian cancer (Closed).
    Chairman and Principal İnvestigator: T Demirer, Ankara University Medical School, Ibn-i Sina Hospital, EBMT Office, Floor 05, Sihhiye, 06100 Ankara, Turkey.
  • A randomised phase 3 study on completely responding metastatic breast cancer. A joint protocol of the EBMT and MDACC. Chairman: T. Demirer (Ankara-Turkey), Principal investigators: G. Hortobagyi, MDACC, Texas, USA ; N. Ueno, MDACC, Texas, USA; and T. Demirer (Ankara-Turkey).
  • A randomised phase 3 study on partially responding metastatic breast cancer. A joint protocol of the EBMT and GITMO.
    Chairman: T. Demirer (Ankara-Turkey), Principal investigators: M. Aglietta and F. Montemurro, Turin, Italy.
  • Phase-II randomized study of intra-familial allogeneic stem cell transplantation for patients suffering from metastatic renal cell carcinoma. A joint protocol of the EBMT and French National Group
    Chairman: T. Demirer (Ankara-Turkey), Principal investigator: D. Blaise (Marseille, France).
  • Meta-analysis project in breast cancer- An international task force on behalf of the EBMT Solid Tumor Working Party Demirer T (Chairman) Project Coordinator (Turkey) Berry A.D, PhD, USA, (American Principal Investigator)